Compare Unichem Lab with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STERLING BIOTECH UNICHEM LAB/
STERLING BIOTECH
 
P/E (TTM) x 62.8 -0.4 - View Chart
P/BV x 0.7 0.0 4,735.3% View Chart
Dividend Yield % 2.1 0.0 -  

Financials

 UNICHEM LAB   STERLING BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
STERLING BIOTECH
Dec-13
UNICHEM LAB/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs29211 2,781.0%   
Low Rs1823 5,352.9%   
Sales per share (Unadj.) Rs167.726.8 625.5%  
Earnings per share (Unadj.) Rs-3.6-15.0 24.3%  
Cash flow per share (Unadj.) Rs5.9-5.5 -108.8%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.354.9 678.3%  
Shares outstanding (eoy) m70.38267.87 26.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.40.3 545.2%   
Avg P/E ratio x-65.3-0.5 14,047.9%  
P/CF ratio (eoy) x39.9-1.3 -3,135.2%  
Price / Book Value ratio x0.60.1 502.8%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,6801,862 896.0%   
No. of employees `0002.61.4 192.2%   
Total wages/salary Rs m2,393547 437.7%   
Avg. sales/employee Rs Th4,535.25,303.3 85.5%   
Avg. wages/employee Rs Th919.8403.8 227.8%   
Avg. net profit/employee Rs Th-98.2-2,959.0 3.3%   
INCOME DATA
Net Sales Rs m11,8017,181 164.3%  
Other income Rs m98443 2,310.1%   
Total revenues Rs m12,7857,223 177.0%   
Gross profit Rs m-835947 -88.2%  
Depreciation Rs m6742,543 26.5%   
Interest Rs m754,377 1.7%   
Profit before tax Rs m-600-5,931 10.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-343-1,924 17.8%   
Profit after tax Rs m-256-4,007 6.4%  
Gross profit margin %-7.113.2 -53.7%  
Effective tax rate %57.332.4 176.5%   
Net profit margin %-2.2-55.8 3.9%  
BALANCE SHEET DATA
Current assets Rs m20,38414,335 142.2%   
Current liabilities Rs m5,02949,809 10.1%   
Net working cap to sales %130.1-494.0 -26.3%  
Current ratio x4.10.3 1,408.4%  
Inventory Days Days105403 26.0%  
Debtors Days Days135171 79.0%  
Net fixed assets Rs m9,02355,432 16.3%   
Share capital Rs m141268 52.6%   
"Free" reserves Rs m26,05813,935 187.0%   
Net worth Rs m26,19914,701 178.2%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m31,49673,988 42.6%  
Interest coverage x-7.0-0.4 1,964.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.40.1 386.0%   
Return on assets %-0.60.5 -114.3%  
Return on equity %-1.0-27.3 3.6%  
Return on capital %-2.0-6.4 31.1%  
Exports to sales %69.425.9 267.9%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs m8,1881,860 440.3%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m8,1881,860 440.3%   
Fx outflow Rs m59625 2,394.5%   
Net fx Rs m7,5921,835 413.8%   
CASH FLOW
From Operations Rs m-3,2781,719 -190.7%  
From Investments Rs m-2,860-3,148 90.8%  
From Financial Activity Rs m-241,426 -1.7%  
Net Cashflow Rs m-4,690-3 137,947.1%  

Share Holding

Indian Promoters % 50.1 33.9 147.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 9.9 30.3%  
ADR/GDR % 0.0 16.9 -  
Free float % 31.7 39.3 80.7%  
Shareholders   20,176 21,482 93.9%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DIVIS LABORATORIES  WOCKHARDT  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 20, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS